Fermenta Biotech Share Price
500.70-1.60 (-0.32%)
+57.26% past 1 Year
DIL Ltd is engaged in the business of research support services through their subsidiary Research Support International Ltd. (RSIL), manufacture and marketing of enzymes and chemicals through their subsidiary Fermenta
Corporate filings & documents
Announcements
Intimation of investor(s) meeting(s) to be held on September 3 2026.
1 week agoIntimation of investor(s) meeting(s) to be held on September 3 2026.
1 week agoWe hereby submit newspaper publication pertaining to Notice for Special window for transfer and dematerialization of physical securities.
1 week agoWe hereby submit newspaper publication pertaining to Notice for Special window for transfer and dematerialization of physical securities.
1 week agoIntimation of investor meeting to be held on August 21 2026.
2 weeks agoIntimation of investor meeting to be held on August 21 2026.
2 weeks agoRevision in credit rating.
2 weeks agoRevision in credit rating.
2 weeks agoNewspaper publication of Unaudited financial results for quarter ended June 30 2026.
3 weeks agoNewspaper publication of Unaudited financial results for quarter ended June 30 2026.
3 weeks agoDeclaration of voting results of the 74th Annual General Meeting.
3 weeks agoScrutinizers report of 74th Annual General Meeting.
3 weeks agoOutcome of 74th Annual General Meeting.
3 weeks agoPresentation for shareholders at 74th Annual General Meeting (AGM)
3 weeks agoPresentation for shareholders at 74th Annual General Meeting (AGM)
3 weeks agoEarnings presentation - Q1/FY27
3 weeks agoEarnings presentation - Q1/FY27
3 weeks agoPress release regarding unaudited financial results of Q1FY27.
3 weeks agoPress release regarding unaudited financial results of Q1FY27.
3 weeks agoUnaudited financial results for quarter ended June 30 2026.
3 weeks agoUnaudited financial results for quarter ended June 30 2026.
3 weeks agoOutcome of Board meeting and unaudited financial results - June 30 2026.
3 weeks agoOutcome of Board meeting and unaudited financial results - June 30 2026.
3 weeks agoIntimation of investor(s) meeting(s).
3 weeks agoIntimation of investor(s) meeting(s).
3 weeks agoFermenta Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve unaudited financial results (standalone and consolidated) for the quarter ended June 30 2026.
1 month agoFermenta Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve unaudited financial results (standalone and consolidated) for the quarter ended June 30 2026.
1 month agoPress release - listing of shares on NSE
1 month agoPress release - listing of shares on NSE
1 month agoIntimation regarding listing of equity shares of Fermenta Biotech Limited on National Stock Exchange of India Limited.
1 month agoIntimation regarding listing of equity shares of Fermenta Biotech Limited on National Stock Exchange of India Limited.
1 month agoIntimation of investor meeting
1 month agoIntimation of investor meeting
1 month agoPursuant to Regulation 30 of SEBI (Listing Obligations and Disclosures Requirements) Regulations 2015 we enclose herewith photocopy of the newspaper advertisement published pertaining to notice of 74th AGM of the Company (post dispatch of Annual Report).
1 month agoPursuant to Regulation 30 of SEBI (Listing Obligations and Disclosures Requirements) Regulations 2015 we enclose herewith photocopy of the newspaper advertisement published pertaining to notice of 74th AGM of the Company (post dispatch of Annual Report).
1 month agoBusiness Responsibility and Sustainability Reporting for Financial Year 2025-26.
1 month agoBusiness Responsibility and Sustainability Reporting for Financial Year 2025-26.
1 month agoNotice of the 74th Annual General Meeting of Fermenta Biotech Limited to be held on August 11 2026.
1 month agoNotice of the 74th Annual General Meeting of Fermenta Biotech Limited to be held on August 11 2026.
1 month agoAnnual Report for Financial Year 2025-26.
1 month agoAnnual Report for Financial Year 2025-26.
1 month agoCessation of subsidiary being a wholly-owned subsidiary pursuant to Share Subscription Agreement entered on July 20 2026.
1 month agoCessation of subsidiary being a wholly-owned subsidiary pursuant to Share Subscription Agreement entered on July 20 2026.
1 month agoIntimation of investor(s) meeting to be held on July 23 2026.
1 month agoIntimation of investor(s) meeting to be held on July 23 2026.
1 month agoIntimation of investor(s) meeting to be held on July 22 2026.
1 month agoIntimation of investor(s) meeting to be held on July 22 2026.
1 month agoClarification on price movement in the Companys shares.
1 month agoClarification on price movement in the Companys shares.
1 month agoThe Exchange has sought clarification from Fermenta Biotech Ltd on July 16 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.
1 month agoAnnual reports
Concalls & investor presentations
Aug 2026
ConcallPresentation
May 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Aug 2025
ConcallPresentation
Feb 2025
ConcallPresentation
Nov 2024
ConcallPresentation
Aug 2024
ConcallPresentation
May 2024
ConcallPresentation
Feb 2024
ConcallPresentation
Nov 2023
ConcallPresentation
Aug 2023
ConcallPresentation
May 2023
ConcallPresentation
Feb 2023
ConcallPresentation
Nov 2022
ConcallPresentation
Aug 2022
ConcallPresentation
Jun 2022
ConcallPresentation
May 2022
ConcallPresentation
Feb 2022
ConcallPresentation
Feb 2022
ConcallPresentation
Nov 2021
ConcallPresentation
Nov 2021
ConcallPresentation
Aug 2021
ConcallPresentation
Jun 2021
ConcallPresentation
Feb 2021
ConcallPresentation
Feb 2021
ConcallPresentation
Feb 2021
ConcallPresentation
Nov 2020
ConcallPresentation
Nov 2020
ConcallPresentation
Nov 2020
ConcallPresentation
Sept 2020
ConcallPresentation
Sept 2020
ConcallPresentation
Corporate Actions
Date
Type
Details
2026-08-05
Dividend
3.75
2025-08-06
Dividend
2.5
2024-08-06
Dividend
1.25
2023-09-22
Dividend
1.25
Company details
Registered office
A 1501, Thane One Dil Complex, Ghodbhunder Road Majiwada Thane Maharashtra PIN: 400610 Tel No: 022-67980888 Fax No: 022-67980899 Email: [email protected] Internet: www.fermentabiotech.com
Registrars
C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra C 101, 247 Park LBS Marg Vikhroli (West) PIN: Tel No: +91 810 811 8484 Fax No: 91-022-49186060 Email: [email protected] Internet: https://in.mpms.mufg.com/
Management
Varadvinayak Vijay Khambete, Company Secretary & Compliance Officer, Head - Legal
Pradeep M Chandan, Chairman
Krishna Datla, Vice Chairman
Prashant Nagre, Managing Director
Anupama Datla Desai, Executive Director
Satish Varma, Executive Director
Rajeshwari Datla, Non Executive Director
Pramod Kasat, Non Executive Independent Director
Rajashri Ojha, Non Executive Independent Director
Ramanand Mundkur, Non Executive Independent Director
Details
BSE 506414
NSE FERMENTA
ISIN INE225B01021